Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000029636 | SCV000052288 | uncertain | Congenital adrenal hyperplasia | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Uncertain significance. |
Ambry Genetics | RCV002513246 | SCV003713351 | uncertain significance | Inborn genetic diseases | 2021-10-20 | criteria provided, single submitter | clinical testing | The c.1016C>T (p.A339V) alteration is located in exon 6 (coding exon 6) of the CYP11B1 gene. This alteration results from a C to T substitution at nucleotide position 1016, causing the alanine (A) at amino acid position 339 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |